Skip to main content
Premium Trial:

Request an Annual Quote

Linday Avey, Michele Cargill, Geoffrey Ginsburg, Stuart Kim, and Eric Rasmussen

Exploragen has appointed Linday Avey, Michele Cargill, Geoffrey Ginsburg, Stuart Kim, and Eric Rasmussen to its advisory board. Avey is a co-founder of 23andMe and of, as well as a member of the Board of Fellows at Stanford University School of Medicine; Cargill is a co-founder and fellow at Invitae; Ginsburg is professor of medicine and biomedical engineering at Duke University and the founder of the Global Genomic Medicine Collaborative; Rasmussen is vice president of consumer insights at Groupon; and Kim is professor emeritus of developmental biology and genetics at Stanford University. 

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.